Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by lonc17on Dec 13, 2023 7:43pm
172 Views
Post# 35783451

RE:Idle Evening Thoughts

RE:Idle Evening ThoughtsPelaboost,

I also think that MC will not exercies his options (those that expire today).

But consider the message this sends.

He is the only person on the planet that can buy ONC shares today at a price of $1.45 CDN. He is the CEO. He has inside knowledge and has a clear idea of ONC's potential and short term future better than anyone. And he takes a pass??

Well, in my opinion he will be announcing to the world that ONC is not worth $1.45 CDN today, and he is also forecasting that he does not see any hope for an increase in value during his remaining tenure at ONC.

He may as well buy a full page adverisment and announce that ONC will never partner with Big Pharma.

What a shame and what a lousy CEO.

<< Previous
Bullboard Posts
Next >>